NSE filing, NSE: TORNTPOWER. Summary written from the filing by ALFA Finder's alert engine.
Torrent Power Ltd: key numbers
- Share price
- ₹1,172.90
- Market cap
- ₹59,103 Cr
- Revenue (annual)
- ₹28,966 Cr
- Net profit (annual)
- ₹2,416 Cr
- P/E (TTM)
- 25.4×Sector 21.6×
- Promoter holding
- 51.09%+0.00% QoQ
- FII holding
- 8.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Torrent Power Ltd
All →Torrent Power Board Meeting Date
Torrent Power schedules a board meeting on 4 November 2026 to approve unaudited standalone and consolidated results for Q2 and half year. The notice carries no financial figures.
Torrent Power Credit Rating
India Ratings and CRISIL assigned AA+ ratings to proposed NCDs and reaffirmed existing ratings for Torrent Power. The company's outlook is stable across both agencies.
Torrent Power Other Announcement
Torrent Power Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Torrent Power Other Announcement
The company submitted the compliance certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018, for the quarter ended September 30, 2026.
Torrent Power Adverse Business Impact
Torrent Power's subsidiary terminated a 300 MW wind power PPA with SECI due to implementation uncertainties. Liquidated damages of ₹39.78 crore are payable upon termination.
- Value
- ₹39.78 Cr
- From
- Solar Energy Corporation of India Limited
- wind power capacity
- 300.0 MW
Torrent Power Production Started
Torrent Power commissions 322 MWp of decentralized solar projects in Nashik under MSKVY 2.0. Power will be supplied to MSEDCL under a 25-year PPA.
- Execution
- 25 years (PPA with MSEDCL)
- solar generation capacity
- 322 MWp
Other regulatory approval announcements
All →Grasim Industries Regulatory Approval
CCI approved subsidiary ABReN's acquisition of 100% of Solenergi Power from Shell Overseas. The approval clears a regulatory condition for the deal announced on 13 July 2026.
Vedavaag Systems Regulatory Approval
Vedavaag's WOS received IRDAI Certificate of Registration to act as Direct Life & General Insurance Broker. The group enters regulated insurance broking activity.
Hikal Regulatory Approval
Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.
RNFI Services Regulatory Approval
RNFI received RBI no-objection to acquire control of Smart Payment Solutions Private Limited. Remaining tranches may proceed, but no transaction value is disclosed.
Shalby Regulatory Approval
Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.